To address this issue, the present study analyzed the expression of 12 protease-type ADAMs in HCC cell lines and found that ADAM21 was overexpressed in the highly motile and metastatic KYN-2 HCC cell line. The gene discussed is ADAM21; the disease is hepatocellular carcinoma.